C Lacour

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 247 citations · Full text

Molecular Pharmacology, Selective Affinity, Arginine Vasopressin +14

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 207 citations · Full text

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

Catherine Cazaubon, Jean Gougat, F Bousquet et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 189 citations

A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists

C. BERNHART, Pierre Perreaut, B. Ferrari et al. · Journal of Medicinal Chemistry · 1993 · 108 citations · Full text

Central Imidazole Nucleus, Health Sciences, Imidazole Series +12